This initiative aligns with the World Health Organization’s Global Strategy for the Elimination of Cervical Cancer by 2050. Dr. Silvia Lutucuta, Angola’s Minister of Health, emphasized the government’s commitment to protecting the health and future of girls by preventing this preventable disease.

A Crucial Tool for a Healthier Future

The HPV vaccine is recognized as a highly effective and safe tool for preventing cervical cancer, a leading cause of cancer deaths among women in Africa. Dr. Zabulon Yoti, Acting Representative of the World Health Organization in Angola, applauded the government’s effort, stating that by guaranteeing vaccination, Angolan girls can grow up in a world where cervical cancer is not a death sentence.

Addressing a Public Health Challenge

Cervical cancer disproportionately affects women in Africa, with estimates from WHO suggesting that around 117,300 women are diagnosed annually, and over 76,000 succumb to the disease. Angola is no exception, with reported cases exceeding 900 in 2022 alone. This campaign aims to drastically reduce the incidence of cervical cancer and contribute to a healthier Angolan population.

Collaboration for Success

The Angolan government, in collaboration with partners like UNICEF, has secured a safe and effective vaccine pre-qualified by WHO. The campaign requires one dose per individual, with over 50 million doses already administered worldwide with no adverse reactions reported.

Beyond Vaccination

The Angolan government, with support from partners, is working on additional measures to ensure the success of the campaign. This includes planning, logistics, training healthcare workers, community engagement, and monitoring the program’s effectiveness.

This HPV vaccination campaign signifies a crucial step towards a healthier future for Angolan girls and women. By prioritizing preventative measures, Angola is setting a strong example and aligning with global efforts to eliminate cervical cancer.